CureVac NV (5CV) — Cash Flow Quality Index
CureVac NV (5CV) has a Cash Flow Quality Index of 0.11x as of September 2025. Operating cash flow of €29.86 Million is below net income of €273.23 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of CureVac NV to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CureVac NV Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for CureVac NV across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 5CV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CureVac NV (2024–2024)
Year-by-year earnings quality comparison for CureVac NV. For live market cap and the full company financial profile, see market cap of CureVac NV.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | €101.85 Million | €162.19 Million | — |